347 related articles for article (PubMed ID: 24529008)
1. Prospective multi-center study elucidating patient experience after prostatic urethral lift.
Shore N; Freedman S; Gange S; Moseley W; Heron S; Tutrone R; Brown T; Barkin J
Can J Urol; 2014 Feb; 21(1):7094-101. PubMed ID: 24529008
[TBL] [Abstract][Full Text] [Related]
2. Three year results of the prostatic urethral L.I.F.T. study.
Roehrborn CG; Rukstalis DB; Barkin J; Gange SN; Shore ND; Giddens JL; Bolton DM; Cowan BE; Cantwell AL; McVary KT; Te AE; Gholami SS; Moseley WG; Chin PT; Dowling WT; Freedman SJ; Incze PF; Coffield KS; Borges FD; Rashid P
Can J Urol; 2015 Jun; 22(3):7772-82. PubMed ID: 26068624
[TBL] [Abstract][Full Text] [Related]
3. Minimally invasive prostatic urethral lift: surgical technique and multinational experience.
McNicholas TA; Woo HH; Chin PT; Bolton D; Fernández Arjona M; Sievert KD; Schoenthaler M; Wetterauer U; Vrijhof EJ; Gange S; Montorsi F
Eur Urol; 2013 Aug; 64(2):292-9. PubMed ID: 23357348
[TBL] [Abstract][Full Text] [Related]
4. Multicentre prospective crossover study of the 'prostatic urethral lift' for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.
Cantwell AL; Bogache WK; Richardson SF; Tutrone RF; Barkin J; Fagelson JE; Chin PT; Woo HH
BJU Int; 2014 Apr; 113(4):615-22. PubMed ID: 24765680
[TBL] [Abstract][Full Text] [Related]
5. The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. Study.
Roehrborn CG; Gange SN; Shore ND; Giddens JL; Bolton DM; Cowan BE; Brown BT; McVary KT; Te AE; Gholami SS; Rashid P; Moseley WG; Chin PT; Dowling WT; Freedman SJ; Incze PF; Coffield KS; Borges FD; Rukstalis DB
J Urol; 2013 Dec; 190(6):2161-7. PubMed ID: 23764081
[TBL] [Abstract][Full Text] [Related]
6. Prostatic Urethral Lift: A New Minimally Invasive Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
Bozkurt A; Karabakan M; Keskin E; Hirik E; Balci MB; Nuhoglu B
Urol Int; 2016; 96(2):202-6. PubMed ID: 26613256
[TBL] [Abstract][Full Text] [Related]
7. Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study.
Roehrborn CG; Barkin J; Gange SN; Shore ND; Giddens JL; Bolton DM; Cowan BE; Cantwell AL; McVary KT; Te AE; Gholami SS; Moseley WG; Chin PT; Dowling WT; Freedman SJ; Incze PF; Coffield KS; Herron S; Rashid P; Rukstalis DB
Can J Urol; 2017 Jun; 24(3):8802-8813. PubMed ID: 28646935
[TBL] [Abstract][Full Text] [Related]
8. Safety and feasibility of the prostatic urethral lift: a novel, minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH).
Woo HH; Chin PT; McNicholas TA; Gill HS; Plante MK; Bruskewitz RC; Roehrborn CG
BJU Int; 2011 Jul; 108(1):82-8. PubMed ID: 21554526
[TBL] [Abstract][Full Text] [Related]
9. 24-month durability after crossover to the prostatic urethral lift from randomised, blinded sham.
Rukstalis D; Rashid P; Bogache WK; Tutrone RF; Barkin J; Chin PT; Woo HH; Cantwell AL; Cowan BE; Bolton DM
BJU Int; 2016 Oct; 118 Suppl 3():14-22. PubMed ID: 27684483
[TBL] [Abstract][Full Text] [Related]
10. Prospective, randomized, multinational study of prostatic urethral lift versus transurethral resection of the prostate: 12-month results from the BPH6 study.
Sønksen J; Barber NJ; Speakman MJ; Berges R; Wetterauer U; Greene D; Sievert KD; Chapple CR; Montorsi F; Patterson JM; Fahrenkrug L; Schoenthaler M; Gratzke C
Eur Urol; 2015 Oct; 68(4):643-52. PubMed ID: 25937539
[TBL] [Abstract][Full Text] [Related]
11. Prostatic urethral lift: a novel approach for managing symptomatic BPH in the aging man.
Rukstalis DB
Can J Urol; 2015 Oct; 22 Suppl 1():67-74. PubMed ID: 26497346
[TBL] [Abstract][Full Text] [Related]
12. Treatment of LUTS secondary to BPH while preserving sexual function: randomized controlled study of prostatic urethral lift.
McVary KT; Gange SN; Shore ND; Bolton DM; Cowan BE; Brown BT; Te AE; Chin PT; Rukstalis DB; Roehrborn CG;
J Sex Med; 2014 Jan; 11(1):279-87. PubMed ID: 24119101
[TBL] [Abstract][Full Text] [Related]
13. Preservation of sexual function with the prostatic urethral lift: a novel treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia.
Woo HH; Bolton DM; Laborde E; Jack G; Chin PT; Rashid P; Thavaseelan J; McVary KT
J Sex Med; 2012 Feb; 9(2):568-75. PubMed ID: 22172161
[TBL] [Abstract][Full Text] [Related]
14. Minimally invasive prostatic urethral lift (PUL) efficacious in TURP candidates: a multicenter German evaluation after 2 years.
Sievert KD; Schonthaler M; Berges R; Toomey P; Drager D; Herlemann A; Miller F; Wetterauer U; Volkmer B; Gratzke C; Amend B
World J Urol; 2019 Jul; 37(7):1353-1360. PubMed ID: 30283994
[TBL] [Abstract][Full Text] [Related]
15. Prostatic urethral lift: two-year results after treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia.
Chin PT; Bolton DM; Jack G; Rashid P; Thavaseelan J; Yu RJ; Roehrborn CG; Woo HH
Urology; 2012 Jan; 79(1):5-11. PubMed ID: 22202539
[TBL] [Abstract][Full Text] [Related]
16. Prostatic urethral lift improves urinary symptoms and flow while preserving sexual function for men with benign prostatic hyperplasia: a systematic review and meta-analysis.
Perera M; Roberts MJ; Doi SA; Bolton D
Eur Urol; 2015 Apr; 67(4):704-13. PubMed ID: 25466940
[TBL] [Abstract][Full Text] [Related]
17. Prostatic Urethral Lift: A Unique Minimally Invasive Surgical Treatment of Male Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
Roehrborn CG
Urol Clin North Am; 2016 Aug; 43(3):357-69. PubMed ID: 27476128
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of Rezūm System Water Vapor Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
Dixon C; Cedano ER; Pacik D; Vit V; Varga G; Wagrell L; Tornblom M; Mynderse L; Larson T
Urology; 2015 Nov; 86(5):1042-7. PubMed ID: 26216644
[TBL] [Abstract][Full Text] [Related]
19. Prostatic urethral lift vs transurethral resection of the prostate: 2-year results of the BPH6 prospective, multicentre, randomized study.
Gratzke C; Barber N; Speakman MJ; Berges R; Wetterauer U; Greene D; Sievert KD; Chapple CR; Patterson JM; Fahrenkrug L; Schoenthaler M; Sonksen J
BJU Int; 2017 May; 119(5):767-775. PubMed ID: 27862831
[TBL] [Abstract][Full Text] [Related]
20. Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study.
Sacco E; Bientinesi R; Marangi F; Totaro A; D'Addessi A; Racioppi M; Pinto F; Vittori M; Bassi P
BJU Int; 2012 Dec; 110(11 Pt C):E837-44. PubMed ID: 22712582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
